Cleveland Clinic researchers have discovered a new bacterium that weakens the immune system in the gut. The findings pave the way for potential new treatments for a variety of inflammatory and ...

Flagship Pioneering introduced the latest company, Mirai Bio, during the BioProcess International Conference in Boston.

MED6-189 targets and disrupts the parasite’s apicoplast and also vesicular trafficking pathways, a dual mode of action that ...

As Congress wrangles over a budget for the 2025 federal fiscal year, which begins October 1, the NIH will be paying especially close attention. Last year, the NIH saw its first year-over-year funding ...

Researchers suggest the DeepRVAT model is the first to use artificial intelligence (AI) in genomic association studies to decipher rare genetic variants.